UBC Faculty Research and Publications

Routine VTE prophylaxis : Is there a net health benefit? Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 120 explores whether or not there is a net health benefit for routine venous thromboembolism (VTE) prophylaxis. Conclusions: The risk of symptomatic VTE in hospitalized medical patients is less than 2%. Prophylaxis with low molecular weight heparins does not reduce all-cause mortality. Prophylaxis has unknown effects on PE/DVT (due to missing outcome data), but increases the risk of major bleeds. Risk assessment tools for DVT (such as IMPROVE RAM) can identify patients at low risk of VTE.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International